CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis

Neurology: Neuroimmunology and NeuroInflammation

Volumn 1, Issue 4, 2014, Pages

  Mori, Francesco ^a,c   Ljoka, Concetta ^b   Nicoletti, Carolina G ^a,c   Kusayanagi, Hajime ^a,c   Buttari, Fabio ^a,c   Giordani, Laura ^b   Rossi, Silvia ^a,c   Foti, Calogero ^b   Centonze, Diego ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; GENOMIC DNA;

ADULT; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; FEMALE; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; KINESIOTHERAPY; LONG TERM POTENTIATION; MALE; MIDDLE AGED; MOTOR CORTEX; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT TANDEM REPEAT; THERAPY EFFECT; THETA RHYTHM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; TRINUCLEOTIDE REPEAT;

EID: 85013161224     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000048     Document Type: Article

References (40)

1. Lin TW, Kuo YM. Exercise benefits brain function: the monoamine connection. Brain Sci 2013;3:39-53.
2. Taubert M, Lohmann G, Margulies DS, Villringer A, Ragert P. Long-term effects of motor training on resting-state networks and underlying brain structure. Neuroimage 2011;57:1492-1498.
3. Chen R, Cohen LG, Hallett M. Nervous system reorganization following injury. Neuroscience 2002;111:761-773.
4. Kesselring J, Beer S. Symptomatic therapy and neuroreha-bilitation in multiple sclerosis. Lancet Neurol 2005;4: 643-652.
5. Madroñal N, Gruart A, Valverde O, Espadas I, Moratalla R, Delgado-García JM. Involvement of canna-binoid CB1 receptor in associative learning and in hippocampal CA3-CA1 synaptic plasticity. Cereb Cortex 2012; 22:550-566.
6. Koch G, Mori F, Codecà C, et al. Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans. Brain Stimul 2009;2:229-233.
7. Mori F, Codecà C, Kusayanagi H, et al. Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis. Eur J Neurol 2010;17:295-300.
8. Mori F, Ljoka C, Magni E, et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. J Neurol 2011;258:1281-1287.
9. ∗ (Sativex(®)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 2011; 18:1122-1131.
10. De Chiara V, Errico F, Musella A, et al. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology 2010;35:374-387.
11. Rossi S, Furlan R, De Chiara V, et al. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis. Neurobiol Dis 2009;36:51-59.
12. Zhang PW, Ishiguro H, Ohtsuki T, et al. Human canna-binoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysub-stance abuse. Mol Psychiatry 2004;9:916-931.
13. Rossi S, Bozzali M, Bari M, et al. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. PLoS One 2013;8:e82848. doi:10.1371/journal.pone.0082848.
14. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
15. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993; 471:501-519.
16. Hanajima R, Ugawa Y, Terao Y, et al. Mechanisms of intracortical I-wave facilitation elicited with paired-pulse magnetic stimulation in humans. J Physiol 2002;538: 253-261.
17. Valls-Solé J, Pascual-Leone A, Wassermann EM, Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol 1992;85:355-364.
18. White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports Med 2004;34:1077-1100.
19. Rossi S, Buttari F, Studer V, et al. The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Mult Scler 2011; 17:281-288.
20. De Roo M, Klauser P, Garcia PM, Poglia L, Muller D. Spine dynamics and synapse remodeling during LTP and memory processes. Prog Brain Res 2008;169:199-207.
21. Tyc F, Boyadjian A, Devanne H. Motor cortex plasticity induced by extensive training revealed by transcranial magnetic stimulation in human. Eur J Neurosci 2005;21:259-266.
22. Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur J Appl Physiol 2013; 113:869-875.
23. Dubreucq S, Durand A, Matias I, et al. Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance. Biol Psychiatry 2013;73:895-903.
24. Baker D, Pryce G, Croxford JL, et al. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 2000;404:84-87.
25. Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014;82:1556-1563.
26. Di Lazzaro V, Pilato F, Saturno E, et al. Theta-burst repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex. J Physiol 2005;565:945-950.
27. Auclair N, Otani S, Soubrie P, Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 2000;83:3287-3293.
28. Liu HL, Zhao G, Cai K, Zhao HH, Shi LD. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal longterm potentiation. Behav Brain Res 2011;218:308-314.
29. Coelho FG, Gobbi S, Andreatto CA, Corazza DI, Pedroso RV, Santos-Galduróz RF. Physical exercise modulates peripheral levels of brain-derived neurotrophic factor (BDNF): a systematic review of experimental studies in the elderly. Arch Gerontol Geriatr 2013;56:10-15.
30. Cheeran B, Talelli P, Mori F, et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 2008;586:5717-5725.
31. Kleim JA, Chan S, Pringle E, et al. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci 2006;9:735-737.
32. Centonze D, Bari M, Rossi S, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain 2007;130: 2543-2553.
33. Cutando L, Busquets-Garcia A, Puighermanal E, et al. Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J Clin Invest 2013;123: 2816-2831.
34. Rossi S, Sacchetti L, Napolitano F, et al. Interleukin-1b causes anxiety by interacting with the endocannabinoid system. J Neurosci 2012;32:13896-13905.
35. Mori F, Rossi S, Piccinin S, et al. Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis. J Neurosci 2013;33:19112-19119.
36. Mori F, Nicoletti CG, Rossi S, et al. Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis. Neuromolecular Med 2014;16:490-498.
37. Goldsworthy MR, Pitcher JB, Ridding MC. The application of spaced theta burst protocols induces long-lasting neuroplastic changes in the human motor cortex. Eur J Neurosci 2012;35:125-134.
38. Ramil E, Sánchez AJ, González-Pérez P, et al. The canna-binoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain. Mult Scler 2010;16:139-146.
39. Mori F, Kusayanagi H, Nicoletti CG, Weiss S, Marciani MG, Centonze D. Cortical plasticity predicts recovery from relapse in multiple sclerosis. Mult Scler 2014;20:451-457.
40. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008;9:516-526.